Catechol: A minimal scaffold for non-peptide peptidomimetics of the i + 1 and i + 2 positions of the β-turn of somatostatin

Organic Letters

Volumn 8, Issue 20, 2006, Pages 4397-4400

  Mowery, Brendan P ^a   Prasad, Vidya ^a   Kenesky, Craig S ^a   Angeles, Angie R ^a   Taylor, Laurie L ^b   Feng, Jin Jye ^c   Chen, Wen Long ^c   Lin, Atsui ^c   Cheng, Fong Chi ^c   Smith III, Amos B ^a   Hirschmann, Ralph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MDS Inc   (Canada)

^c MDS Pharma Services   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL; CATECHOL DERIVATIVE; SOMATOSTATIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; MOLECULAR MIMICRY;

CATECHOLS; MODELS, MOLECULAR; MOLECULAR MIMICRY; SOMATOSTATIN;

EID: 33750049676     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol061488x     Document Type: Article

References (30)

1. Veber, D. F.; Holly, F. W.; Paleveda, W. J.; Nutt, R. F.; Bergstrand, S. J.; Torchiana, M.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 2636.
2. Vale, W.; Rivier, J.; Ling, N.; Brown, M. Metab., Clin. Exp. 1978, 27, 1391,
3. Veber, D. F.; Freidinger, R. M.; Perlow, D. S.; Paleveda, W. J., Jr.; Holly, F. W.; Strachan, R. G.; Nutt, R. F.; Arison, B. H.; Homnick, C.; Randall, W. C.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. Nature 1981, 292, 55.
4. Walter, R. Fed. Proc. 1977, 36, 1872.
5. (a) Freidinger, R. M.; Veber, D. F. Conformationally Directed Drug Design, Peptides and Nucleic Acids as Templates of Targets; Vida, J., Gordon, M., Eds.; American Chemical Society: Washington, DC, 1984; p 169.
6. (b) Arison, B. H.; Saperstein, R. In Peptides: Structure and Function, Proceedings of the 8th American Peptide Symposium; Hruby, V. J., Rich, D., Eds.; Pierce Chemical Co.: Rockford, IL, 1983; p 349.
7. (a) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Salvino, J.; Leahy, E. M.; Sprengeler, P. A.; Furst, G.; Smith, A. B., III; Strader, C. D.; Cascieri, M. A.; Candelore, M. R.; Donaldson, C.; Vale, W.; Maechler, L. J. Am. Chem. Soc. 1992, 114, 9217.
8. (b) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Leahy, E. M.; Salvino, J.; Arison, B.; Cichy, M. A.; Spoors, P. G.; Shakespeare, W. C.; Sprengeler, P. A.; Hamley, P.; Smith, A. B., III; Reisine, T.; Raynor, K.; Maechler, L.; Donaldson, C.; Vale, W.; Freidinger, R. M.; Cascieri, M. R.; Strader, C. D. J. Am. Chem. Soc. 1993, 115, 12550.
9. Brown, M.; Rivier, J.; Vale, W.; Guillemin, R. Biochem. Biophys. Res. Commun. 1975, 65, 752.
10. Contour-Galcéra, M.-O.; Sidhu, A.; Plas, P.; Roubert, P. Bioorg. Med. Chem. Lett. 2005, 13, 3555.
11. Contour-Galcéra, M.-O.; Poitout, L.; Moinet, C.; Morgan, B.; Gordon, T.; Roubert, P.; Thurieau, C. Bioorg. Med. Chem. Lett. 2001, 11, 741.
12. Poitout, L.; Roubert, P.; Contour-Galcéra, M.-O.; Moinet, C.; Lannoy, J.; Pommier, J.; Plas, P.; Bigg, D.; Thurieau, C. J. Med. Chem. 2001, 44, 2990.
13. Hiroshi, M.; Suzuki, N.; Miki, T. WO Patent Appl. 98-JP1797, 1998.
14. (a) Souers, A. J.; Virgilio, A. A.; Rosenquist, Å.; Fenuik, W.; Ellman, J. A. J. Am. Chem. Soc. 1999, 121, 1817-1825.
15. (b) Souers, A. J.; Rosenquist, Å.; Jarvie, E. M.; Ladlow, M.; Fenuik, W.; Ellman, J. A. Bioorg., Med. Chem. Lett. 2000, 10, 2731-2733.
16. Veber, D. F. In Peptides-Chemistry and Biology: Proceedings of the 12th American Peptide Symposium; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; p 3.
17. Snyder, H. R.; Eliel, E. L. J. Am. Chem. Soc. 1948, 70, 1703.
18. Prasad, V.; Birzin, E. T.; McVaugh, C. T.; van Rijn, R. D.; Rohrer, S. P.; Chicchi, G.; Underwood, D. J.; Thornton, E. R.; Smith, A. B., III; Hirschmann, R. J. Med. Chem. 2003, 46, 1858.
19. Meyers, C. A.; Coy, D. H.; Huang, W. Y.; Schally, A. V.; Redding, T. W. Biochemistry 1978, 17, 2326.
20. Crider, A. M.; Liu, S.; Li, T.; Mahajan, A.; Ankersen, M.; Stidsen, C. E. Lett. Drug Des. Discuss. 2004, 1, 84.
21. (a) Formation of 5-fluoro-3-(2-hydroxyethyl)indole from 5-fluoroindol-3-ylacetic acid: Mewshaw, R. E.; Zhou, D.; Zhou, P.; Shi, X.; Hornby, G.; Spangler, T.; Scerni, R.; Smith, D.; Schechter, L. E.; Andree, T. H. J. Med. Chem. 2004, 47, 3823.
22. (b) Silylation of 5-fluorotryptophol: RajanBabu, T. V.; Chenard, B. L.; Petti, M. A. J. Org. Chem. 1986, 51, 1704.
23. (a) Staudinger, H.; Meyer, J. Helv. Chim. Acta 1919, 2, 635.
24. (b) Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88, 297.
25. (c) Gololobov, Y. G.; Kasukhin, L. F. Tetrahedron 1992, 48, 1353.
26. (a) Bungard, C. J.; Morris, J. C. Synthesis 2001, 741.
27. (b) Ishizaki, M.; Ozaki, K.; Kanematsu, A.; Isoda, T.; Hoshino, O. J. Org. Chem. 1993, 58, 3877.
28. (a) Stahl, P.; Kissau, L.; Mazitschek, R.; Giannis, A.; Waldmann, H. Angew. Chem., Int. Ed. 2002, 44, 1174.
29. (b) Kissau, L.; Stahl, P.; Mazitschek, R.; Giannis, A.; Waldmann, H. J. Med. Chem. 2003, 46, 2917.
30. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Delivery Rev. 1997, 23, 3.